A clinical trial to study the effects of two drugs, amitriptyline and pregabalin in patients with chronic low back pai
Phase 4
Completed
- Conditions
- Health Condition 1: null- chronic low back pain
- Registration Number
- CTRI/2012/07/002833
- Lead Sponsor
- proff u k misra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Chronic low-back pain (symptoms duration > 3 month)
Age:[ > 18 yrs to 75 yrs]
Informed consent
Exclusion Criteria
Previous back surgery
Diabetic and other neuropathies
Infective or structural diseases of back (e.g. Potts spine , malignancies)
Cardiac or renal disease
History of gastric ulcers or intestinal bleeding
Known allergy to the drugs under study
Alcohol or drug abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mean pain reduction and disability improvement following allotted treatment regimenTimepoint: 14 weeks
- Secondary Outcome Measures
Name Time Method adverse effects due to the allotted drugTimepoint: 14 weeks